Reduced cardiac123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson’s disease
✍ Scribed by Rosa, Anna; Pappatà, Sabina; Pellegrino, Teresa; Leva, Maria Fulvia; Maddaluno, Gennaro; Fiumara, Giovanni; Carotenuto, Raffaella; Petretta, Mario; Filla, Alessandro; Michele, Giuseppe; Cuocolo, Alberto
- Book ID
- 121605027
- Publisher
- Springer
- Year
- 2013
- Tongue
- English
- Weight
- 263 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To analyze the correlation between muscle sympathetic nerve activity (MSNA) and cardiac ^123^I‐metaiodobenzylguanidine (MIBG) uptake in patients with Parkinson's disease (PD), we measured both parameters in 14 PD patients who were 51 to 82 years of age (mean, 63.1 ± 8.7 years). The dura
## Abstract Among 242 patients with apparently sporadic Parkinson's disease, a 70‐year‐old man with a CAG repeat number of 37 in the __SCA2__ gene was identified. He has remained responsive to levodopa 14 years after onset and has had no overt signs suggesting cerebellar dysfunction. Although it is